Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib (NCT02226172) | Pfizer | 2014-10-06 |
Track Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis automatically
Every clearance here is in the API, with alerts when new ones post.